tegaserod, Zelnorm (cont.)
Following release of tegaserod, a safety analysis showed an excess number of serious cardiovascular adverse events, including angina, heart attacks, and stroke, in patients taking tegaserod compared to patients taking placebo. Therefore, patients should seek emergency medical care if they experience severe chest pain, shortness of breath, sudden onset of weakness or difficulty walking or talking, or other symptoms of a heart attack or stroke.
Reference: FDA Prescribing Information
Last Editorial Review: 4/21/2008
Back to Medications Index
Get the latest health and medical information delivered direct to your inbox FREE!